Request Services Now
CTSA

NCATS Announces Funding Opportunities to Repurpose Drug Candidates from Industry

New Therapies for PatientsNCATS is now accepting applications for its Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses) program. 

Interested researchers can submit a pre-application by July 15, 2014, in response to the funding announcements on NCATS’ New Therapeutics Funding Information Web page. Applicants must describe how they would explore specific hypotheses for an agent available through the program and how it might be used in a specific disease. Pre-applications will undergo NIH review, and successful applicants will be placed in contact with the pharmaceutical company providing the agent to discuss the submission of an application for funding that would begin in July 2015. In addition to NCATS, multiple NIH Institutes and Centers and the Food and Drug Administration’s Office of Orphan Products Development are contributing funding for these announcements.